Cardioprotection during cardiac surgery

Area of Science:

• Cardiology
• Cardiac Surgery
• Cardioprotection

Background:

• Coronary heart disease (CHD) is a global health burden, with coronary artery bypass graft (CABG) surgery as a primary revascularization strategy.
• An increasing number of high-risk patients, characterized by advanced age and comorbidities, undergo CABG, leading to poorer clinical outcomes.
• These patients are highly susceptible to peri-operative myocardial injury (PMI), often caused by ischemia/reperfusion injury during surgery.

Purpose of the Study:

• To review the causes, diagnosis, and clinical impact of PMI in CABG surgery.
• To explore current and potential therapeutic strategies for preventing PMI in high-risk patients.
• To highlight the importance of enhanced cardioprotection in improving outcomes for this vulnerable population.

Main Methods:

• Literature review of peri-operative myocardial injury (PMI) in coronary artery bypass graft (CABG) surgery.
• Analysis of the aetiology, diagnosis, and clinical significance of PMI.
• Evaluation of endogenous and pharmacological cardioprotective strategies.

Main Results:

• Peri-operative myocardial injury (PMI) is a significant complication in high-risk coronary artery bypass graft (CABG) patients.
• Inadequate myocardial protection during CABG surgery, leading to ischemia/reperfusion injury, is a major cause of PMI.
• Existing literature suggests a need for novel therapeutic strategies to mitigate PMI.

Conclusions:

• Improving cardioprotection during CABG surgery is crucial for high-risk patients.
• Reducing PMI can preserve left ventricular systolic function.
• Effective cardioprotection strategies may decrease morbidity and mortality in high-risk CHD patients undergoing CABG.